View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Pulmonary Vascular Disease News

SPONSORED CONTENT
Save
SPONSORED CONTENT
August 22, 2023
3 min read
Save

Workshop aims to expand use of point-of-care ultrasonography

Workshop aims to expand use of point-of-care ultrasonography

With its noninvasive and portable nature, point-of-care ultrasonography is an emerging technological tool for critical care clinicians when diagnosing and caring for patients.

SPONSORED CONTENT
August 18, 2023
4 min read
Save

Q&A: Gaps in adoption remain 1 year after new pulmonary hypertension guidelines

Q&A: Gaps in adoption remain 1 year after new pulmonary hypertension guidelines

Guidelines on diagnosing and treating pulmonary hypertension from the European Society of Cardiology and the European Respiratory Society, released 1 year ago, dictated changes in how clinicians care for these patients.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
August 15, 2023
2 min read
Save

Air pollutants linked to heightened risk for pulmonary hypertension, death

Air pollutants linked to heightened risk for pulmonary hypertension, death

Individuals exposed to some ambient air pollutants faced heightened risks for both diagnosis and death of pulmonary hypertension, according to results published in Ecotoxicology and Environmental Safety.

SPONSORED CONTENT
July 27, 2023
2 min read
Save

Radiologic signs may aid early chronic thromboembolic pulmonary hypertension detection

Radiologic signs may aid early chronic thromboembolic pulmonary hypertension detection

Early detection of chronic thromboembolic pulmonary hypertension may be achieved with use of predefined signs on a CT scan following acute pulmonary embolism diagnosis, according to results published in CHEST.

SPONSORED CONTENT
July 13, 2023
3 min read
Save

Inhaled treprostinil safe, improves outcomes in pulmonary hypertension-ILD over 1 year

Inhaled treprostinil safe, improves outcomes in pulmonary hypertension-ILD over 1 year

Inhaled treprostinil was safe in patients with pulmonary hypertension associated with interstitial lung disease over 1 year and sustained improved exercise capacity, according to study results published in European Respiratory Journal.

SPONSORED CONTENT
July 11, 2023
2 min read
Save

Comorbidities, costs among patients with hidradenitis suppurativa continue to rise

Comorbidities, costs among patients with hidradenitis suppurativa continue to rise

Comorbidities, health care utilization and costs are increasing for patients with hidradenitis suppurativa, prompting a need for better disease management, according to a study.

SPONSORED CONTENT
July 03, 2023
3 min read
Save

Management of low-risk patients with pulmonary embolism differs based on CT scan findings

Management of low-risk patients with pulmonary embolism differs based on CT scan findings

Patients presenting with low-risk pulmonary embolism are managed in different ways based on CT scan findings and not clinical risk factors, according to study results published in JAMA Network Open.

SPONSORED CONTENT
June 16, 2023
5 min read
Save

‘Cocaine use is extremely common’: Data suggest testing for drug prior to GPA diagnosis

‘Cocaine use is extremely common’: Data suggest testing for drug prior to GPA diagnosis

Physicians should screen patients for cocaine use before making a diagnosis of granulomatosis with polyangiitis, according to data published in Rheumatology Advances in Practice.

SPONSORED CONTENT
June 06, 2023
3 min read
Save

Combination therapy in patients with new pulmonary arterial hypertension often delayed

Combination therapy in patients with new pulmonary arterial hypertension often delayed

WASHINGTON — Only 8% of patients with pulmonary arterial hypertension initiating combination therapy were given both medications on the same day, according to research presented at the American Thoracic Society International Conference.

SPONSORED CONTENT
May 30, 2023
4 min read
Save

Inhaled seralutinib lowers pulmonary vascular resistance in adults with PAH over 24 weeks

Inhaled seralutinib lowers pulmonary vascular resistance in adults with PAH over 24 weeks

WASHINGTON — In adults with pulmonary arterial hypertension, seralutinib reduced pulmonary vascular resistance over 24 weeks, according to a presentation at the American Thoracic Society International Conference.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails